ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $482,544 | -47.8% | 43,200 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $924,480 | -46.3% | 43,200 | +1.4% | 0.00% | 0.0% |
| Q1 2023 | $1,722,744 | -22.0% | 42,600 | -10.3% | 0.00% | -50.0% |
| Q4 2022 | $2,209,700 | -8.8% | 47,500 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $2,422,000 | +11.4% | 46,700 | +1.5% | 0.00% | +100.0% |
| Q2 2022 | $2,174,000 | -29.5% | 46,000 | +6.2% | 0.00% | -50.0% |
| Q1 2022 | $3,082,000 | +3.0% | 43,300 | +8.2% | 0.00% | 0.0% |
| Q4 2021 | $2,991,000 | +31.6% | 40,000 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $2,272,000 | +29.1% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,760,000 | -8.5% | 40,000 | +2.6% | 0.00% | 0.0% |
| Q1 2021 | $1,923,000 | +18.6% | 39,000 | +1.3% | 0.00% | 0.0% |
| Q4 2020 | $1,621,000 | -8.1% | 38,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,763,000 | -7.1% | 38,500 | +1.9% | 0.00% | -50.0% |
| Q2 2020 | $1,898,000 | +28.6% | 37,800 | +31.7% | 0.00% | 0.0% |
| Q1 2020 | $1,476,000 | -15.6% | 28,700 | +1.4% | 0.00% | 0.0% |
| Q4 2019 | $1,748,000 | +5.0% | 28,300 | +2.2% | 0.00% | 0.0% |
| Q3 2019 | $1,664,000 | -27.2% | 27,700 | +2.2% | 0.00% | 0.0% |
| Q2 2019 | $2,287,000 | -9.6% | 27,100 | +2.3% | 0.00% | -33.3% |
| Q1 2019 | $2,531,000 | +39.1% | 26,500 | +3.1% | 0.00% | +50.0% |
| Q4 2018 | $1,820,000 | -14.8% | 25,700 | +2.8% | 0.00% | 0.0% |
| Q3 2018 | $2,137,000 | -26.3% | 25,000 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $2,898,000 | +43.3% | 25,000 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $2,023,000 | +46.7% | 25,000 | +6.4% | 0.00% | +100.0% |
| Q4 2017 | $1,379,000 | +25.4% | 23,500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,100,000 | +30.0% | 23,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $846,000 | +16.9% | 23,500 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $724,000 | -3.1% | 23,500 | +5.4% | 0.00% | 0.0% |
| Q4 2016 | $747,000 | +26.0% | 22,300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $593,000 | +20.5% | 22,300 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $492,000 | +5.1% | 22,300 | +35.2% | 0.00% | 0.0% |
| Q1 2016 | $468,000 | +5.9% | 16,500 | +23.1% | 0.00% | 0.0% |
| Q4 2015 | $442,000 | -8.7% | 13,400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $484,000 | -8.0% | 13,400 | +14.5% | 0.00% | 0.0% |
| Q2 2015 | $526,000 | +104.7% | 11,700 | +39.3% | 0.00% | 0.0% |
| Q1 2015 | $257,000 | -39.8% | 8,400 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $427,000 | +28.6% | 8,400 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $332,000 | -8.3% | 8,400 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $362,000 | +56.0% | 8,400 | +44.8% | 0.00% | 0.0% |
| Q1 2014 | $232,000 | +98.3% | 5,800 | +34.9% | 0.00% | – |
| Q4 2013 | $117,000 | – | 4,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |